International Business News - WYE http://www.ibtimes.com All articles are copyrighted by IBTimes.com 400 100 http://www.ibtimes.com/ http://www.ibtimes.com/images/top_logo_ibt2_3.gif Profits posted Wednesday by Pfizer Inc. and Wyeth show a common theme among pharmaceutical companies--nearly all the growth they're seeing these days is overseas, driven by emerging markets and the weak dollar. http://www.ibtimes.com/data/articleimgs/96658-earns-pfizer.jpg http://www.ibtimes.com/articles/20080723/weak-dollar-foreign-sales-boost-drugmakers.htm http://www.ibtimes.com/articles/20080723/weak-dollar-foreign-sales-boost-drugmakers.htm Wed, 23 Jul 2008 19:42:35 EDT Shares of drug developer Wyeth rose in premarket trading Wednesday after the company posted strong second-quarter results, and forecast a full-year profit that is above analyst expectations. http://www.ibtimes.com/articles/20080723/ahead-of-the-bell-new-outlook-lifts-wyeth.htm Wed, 23 Jul 2008 08:44:13 EDT Wyeth said Wednesday its second-quarter profit fell 6.3 percent on charges for severance and other costs related to ongoing job cuts, but the drug developer still topped Wall Street expectations and raised its full-year outlook. http://www.ibtimes.com/articles/20080723/wyeth-2q-profit-falls-on-charges-for-job-cuts.htm Wed, 23 Jul 2008 19:11:50 EDT Wyeth, the world's No. 12 drug company by revenue, reports earnings for the second quarter on Wednesday morning. The following is a summary of key developments and analyst opinion related to the period. http://www.ibtimes.com/articles/20080722/flat-earnings-seen-for-drugmaker-wyeth.htm Tue, 22 Jul 2008 19:50:12 EDT Shares of big drug makers fell Friday after a Citi Investment Research gave "Hold" ratings to most of the sector, assigning a top rating only to Merck & Co. and saying Pfizer may need to consider a breakup. http://www.ibtimes.com/articles/20080718/ahead-of-the-bell-pharmaceuticals.htm Fri, 18 Jul 2008 13:54:53 EDT Drug developer Wyeth said Wednesday a U.S. court approved a settlement with generic competitor Impax Laboratories, ending a patent lawsuit over an extended-release version of Wyeth's blockbuster antidepressant Effexor. http://www.ibtimes.com/articles/20080716/wyeth-settles-patent-dispute-with-impax.htm Wed, 16 Jul 2008 17:37:02 EDT Consumer goods company Procter & Gamble Co. agreed to sell its ThermaCare heat wrap business to a unit of drug maker Wyeth on Tuesday. The ThermaCare line includes six kinds of heat wraps, which treat muscle, joint and menstrual pain and minor arthritis pain. The business will be taken over by the Wyeth Consumer Healthcare unit. The companies did not disclose terms but said they expect the deal to close in the next few months. http://www.ibtimes.com/articles/20080715/wyeth-will-buy-thermacare-from-procter-gamble.htm Tue, 15 Jul 2008 15:13:34 EDT Drug company sales representatives will have to stop doling out coffee mugs and pens that push their products when they visit doctor's offices. But they can still sneak in the occasional free lunch. http://www.ibtimes.com/articles/20080711/new-pharma-ethics-rules-eliminate-gifts-and-meals.htm Fri, 11 Jul 2008 05:28:20 EDT Drug company sales representatives will have to stop doling out coffee mugs and pens that push their products when they visit doctor's offices. But they can still sneak in the occasional free lunch. http://www.ibtimes.com/articles/20080710/new-pharma-ethics-rules-eliminate-gifts-and-meals.htm Thu, 10 Jul 2008 17:32:34 EDT A federal judge has thrown out a jury award of more than $27 million for a Little Rock, Ark. woman who developed breast cancer after taking hormone replacement therapy. http://www.ibtimes.com/articles/20080709/ark-judge-tosses-27m-award-in-hormone-drug-suit.htm Wed, 09 Jul 2008 13:14:11 EDT Biotechnology company Elan Corp. could reap blockbuster rewards from its developing Alzheimer's disease drug bapineuzumab, but the drug likely won't hit the market for years, a Cowen and Co. analyst said Tuesday. http://www.ibtimes.com/articles/20080708/cowen-analyst-elan-drug-could-be-a-blockbuster.htm Tue, 08 Jul 2008 14:13:43 EDT Drug developers Wyeth and Progenics Pharmaceuticals Inc. said Thursday European regulators approved Relistor as a treatment for constipation related to pain drugs taken by terminally ill patients. http://www.ibtimes.com/articles/20080703/wyeth-progenics-get-european-constipation-drug-ok.htm Thu, 03 Jul 2008 13:23:23 EDT Shares of Maxygen Inc. jumped Wednesday after the biotechnology company said it is selling its hemophilia treatment program to Bayer's health care division for $90 million, plus up to $30 million in future milestone payments. http://www.ibtimes.com/articles/20080702/maxygen-shares-jump-on-bayer-hemophilia-deal.htm Wed, 02 Jul 2008 18:10:20 EDT Shares of Myriad Genetics Inc. fell Monday morning after the company said it will end development of Alzheimer's disease drug candidate Flurizan, after it proved no better than placebo in a late-stage trial. http://www.ibtimes.com/articles/20080630/out-of-the-gate-myriad-skids-on-flurizan-failure.htm Mon, 30 Jun 2008 11:52:49 EDT Wyeth said Thursday its board has declared dividends on the drug maker's common and preferred stock. A dividend of 28 cents per share on outstanding common stock is payable on Sept. 2 to stockholders of record on Aug. 13. http://www.ibtimes.com/articles/20080627/wyeth-declares-dividends.htm Fri, 27 Jun 2008 17:27:02 EDT Drug maker Wyeth said Friday President and Chief Executive Bernard Poussot will take on the added role of chairman, effective immediately. Poussot, 56, succeeds Robert Essner, 60, who has retired. Essner served as chairman since January 2003 and CEO from 2001 to 2007. http://www.ibtimes.com/articles/20080627/wyeth-ceo-bernard-poussot-takes-on-chairman-role.htm Fri, 27 Jun 2008 09:41:07 EDT Vermont musician Diana Levine won a $6.8 million judgment against drugmaker Wyeth after having part of her right arm amputated in 2000 when an anti-nausea drug was improperly injected. http://www.ibtimes.com/articles/20080626/supreme-court-cases-could-limit-liability-lawsuits.htm Thu, 26 Jun 2008 15:03:48 EDT Pharmaceutical stocks may have ended Wednesday's trading session mostly in the green, but stocks are still down substantially year to date, and a JPMorgan analyst cautioned that big pharma is no longer a strong defensive choice in a weak economy. http://www.ibtimes.com/articles/20080625/sector-wrap-big-pharma.htm Wed, 25 Jun 2008 16:47:05 EDT A JPMorgan analyst placed "Buy" ratings on shares of Merck & Co. and Schering-Plough Corp. Wednesday, but voiced cautions on the pharmaceutical sector and on shares of other major drug makers. http://www.ibtimes.com/articles/20080625/ahead-of-the-bell-major-pharmaceutical-companies.htm Wed, 25 Jun 2008 08:48:49 EDT Shares of Irish drug maker Elan Corp. PLC hit a six-year high Monday as one analyst predicted success for its Alzheimer's disease treatment bapineuzumab, and another voiced skepticism about a rival drug. http://www.ibtimes.com/articles/20080623/adrs-in-focus-elan-climbs-to-6-year-high.htm Mon, 23 Jun 2008 12:32:40 EDT